Loading...
•
Dec 31, 2019
Amedisys Q4 2019 Earnings Report
Amedisys reported strong Q4 2019 financial results, showing increases in net service revenue and net income.
Key Takeaways
Amedisys reported a net service revenue increase of $66.3 million to $500.7 million for Q4 2019, compared to $434.4 million in 2018. Net income attributable to Amedisys, Inc. was $27.7 million, slightly up from $27.5 million in 2018. The company issued its 2020 guidance, anticipating net service revenue between $2.115 billion and $2.160 billion.
Net service revenue increased to $500.7 million from $434.4 million year-over-year.
Net income attributable to Amedisys, Inc. rose to $27.7 million compared to $27.5 million in the previous year.
Adjusted EBITDA reached $52.2 million, up from $43.9 million in 2018.
The company issued 2020 revenue guidance of $2.115 billion to $2.160 billion.
Amedisys
Amedisys
Forward Guidance
Amedisys anticipates net service revenue in the range of $2.115 billion to $2.160 billion, adjusted EBITDA in the range of $250 million to $260 million, and adjusted diluted earnings per share in the range of $4.90 to $5.13.
Positive Outlook
- Net service revenue is anticipated to be in the range of $2.115 billion to $2.160 billion.
- Adjusted EBITDA is anticipated to be in the range of $250 million to $260 million.
- Adjusted diluted earnings per share is anticipated to be in the range of $4.90 to $5.13.
- Guidance is based on an estimated 33.4 million shares outstanding.
- The company is set up for a great 2020 as they navigate the waters of PDGM.
Challenges Ahead
- Guidance excludes the effects of any future acquisitions.
- The home health, hospice and personal care industries are highly competitive.
- The industries are subject to intensive regulations.
- Trends are subject to numerous factors, risks, and uncertainties.
- Future results could differ materially from those described in forward-looking statements.